Evolving Treatment Options for the Treatment of HCC with Immunotherapy and LDT


Activity Info

This activity addresses ongoing research on emerging immunotherapy agents and clinical trial data on the use of these agents in combination, succession, and sequentially with interventional liver directed therapy (LDT).

CME Information is available in the activity.